Silverman Joshua Insider Trades

Insider Trading History

Track insider trading activity for Silverman Joshua. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Petros Pharmaceuticals
Petros Pharmaceuticals PTPI
Director
Holding Value $35.2k 8,790,450 shares
Last Trade
Jun 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.1k 4,375,000 shares
$0.01
$0.00
Q/C Technologies
Q/C Technologies QCLS
Executive Chairman
Holding Value $905k 262,191 shares
Last Trade
Apr 13, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.45
PharmaCyte Biotech
PharmaCyte Biotech PMCB
CEO And President
Holding Value $294k 416,250 shares
Last Trade
Jan 07, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$33.2k 40,000 shares
$0.83
$0.71
PharmaCyte Biotech
PharmaCyte Biotech PMCB
CEO And President
Holding Value $265k 376,250 shares
Last Trade
Jan 06, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$23.7k 30,000 shares
$0.79
$0.71
PharmaCyte Biotech
PharmaCyte Biotech PMCB
CEO And President
Holding Value $244k 346,250 shares
Last Trade
Jan 05, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$23.4k 30,000 shares
$0.78
$0.71
Petros Pharmaceuticals
Petros Pharmaceuticals PTPI
Director
Holding Value $17.7k 4,415,450 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$35k 4,375,000 shares
$0.01
$0.00
PharmaCyte Biotech
PharmaCyte Biotech PMCB
CEO And President
Holding Value $223k 316,250 shares
Last Trade
Dec 12, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$264k 258,750 shares
$1.02
$0.71
PharmaCyte Biotech
PharmaCyte Biotech PMCB
CEO And President
Holding Value $406k 575,000 shares
Last Trade
Dec 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$582k 575,000 shares
$1.01
$0.71
Q/C Technologies
Q/C Technologies QCLS
Executive Chairman
Holding Value $345k 100,029 shares
Last Trade
Nov 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.45
Q/C Technologies
Q/C Technologies QCLS
Executive Chairman
Holding Value $29.9k 8,673 shares
Last Trade
Oct 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.45
Femasys
Femasys FEMY
Director
Holding Value $62.8k 17,600 shares
Last Trade
Jun 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.2k 17,600 shares
$0.98
$3.57
Petros Pharmaceuticals
Petros Pharmaceuticals PTPI
Director
Holding Value $4.04k 1,011,237 shares
Last Trade
Feb 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.94M 1,000,000 shares
$3.94
$0.00
AYRO
AYRO AYRO
Executive Chairman
Holding Value $689k 97,368 shares
Last Trade
Dec 02, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.16M 97,368 shares
$11.90
$7.08
AYRO
AYRO AYRO
Executive Chairman
Holding Value $306k 43,271 shares
Last Trade
Dec 02, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$73.4k 6,166 shares
$11.90
$7.08
AYRO
AYRO AYRO
Executive Chairman
Holding Value $1.34M 189,323 shares
Last Trade
Dec 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.74M 146,052 shares
$11.90
$7.08
Femasys
Femasys FEMY
Director
Holding Value $62.8k 17,600 shares
Last Trade
Jul 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.1k 17,600 shares
$1.14
$3.57
Synaptogenix
Synaptogenix SNPX
Director
Holding Value $6.28k 800 shares
Last Trade
Apr 08, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.31k 800 shares
$5.39
$7.85
Petros Pharmaceuticals
Petros Pharmaceuticals PTPI
Director
Holding Value $160 40,000 shares
Last Trade
Dec 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.41M 40,000 shares
$35.25
$0.00
Femasys
Femasys FEMY
Director
Holding Value $60.7k 17,000 shares
Last Trade
Nov 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.3k 17,000 shares
$0.90
$3.57
PharmaCyte Biotech
PharmaCyte Biotech PMCB
Interim Ceo, Interim President
Holding Value $120k 170,000 shares
Last Trade
Nov 20, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$371k 170,000 shares
$2.18
$0.71

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up